Purpose
Methods and materials
Study design
DSC | MSD (mm) | HD95 (mm) | Nr. of contours by RO using Brouwer et al. guidelines (max = 27) | Nr. of contours by RO using no/other guidelines (max = 35) | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Median | Range | Median | Range | Median | Range | ||||||
Min | Max | Min | Max | Min | Max | ||||||
Brainstem | 0.88 | 0.61 | 0.92 | 1.5 | 1.1 | 4.0 | 4.0 | 2.3 | 15.0 | 24 (89%) | 31 (89%) |
Cochlea left | 0.45 | 0.00 | 0.79 | 1.9 | 0.8 | 11.0 | 3.7 | 1.9 | 14.9 | 16 (59%) | 9 (26%) |
Cochlea right | 0.38 | 0.00 | 0.83 | 2.1 | 0.9 | 10.5 | 4.1 | 1.5 | 14.4 | 16 (59%) | 9 (26%) |
Glottic area | 0.45 | 0.17 | 0.87 | 2.8 | 0.9 | 8.4 | 9.4 | 1.8 | 18.5 | 13 (48%) | 10 (29%) |
Mandible | 0.90 | 0.79 | 0.94 | 1.1 | 0.8 | 8.3 | 3.4 | 1.5 | 38.7 | 26 (96%) | 29 (83%) |
Oral cavity | 0.77 | 0.45 | 0.91 | 4.6 | 1.8 | 11.6 | 14.5 | 4.3 | 30.1 | 19 (70%) | 23 (66%) |
Parotid left | 0.82 | 0.62 | 0.88 | 1.9 | 1.2 | 4.2 | 4.9 | 3.1 | 16.5 | 27 (100%) | 35 (100%) |
Parotid right | 0.83 | 0.51 | 0.90 | 2.0 | 1.4 | 4.9 | 5.1 | 3.2 | 19.2 | 26 (96%) | 35 (100%) |
PCM-inferior | 0.53 | 0.00 | 0.78 | 2.9 | 1.1 | 16.8 | 12.2 | 2.6 | 78.0 | 12 (44%) | 6 (17%) |
Middle | 0.53 | 0.29 | 0.82 | 3.8 | 0.9 | 13.4 | 12.1 | 2.0 | 36.0 | 12 (44%) | 7 (20%) |
Superior | 0.50 | 0.19 | 0.73 | 2.6 | 1.3 | 6.7 | 10.5 | 3.2 | 27.5 | 12 (44%) | 7 (20%) |
Spinal cord | 0.78 | 0.56 | 0.90 | 2.2 | 0.8 | 10.4 | 12.1 | 1.7 | 72.1 | 17 (63%) | 34 (97%) |
SMG left | 0.87 | 0.57 | 0.91 | 1.3 | 0.9 | 3.4 | 3.1 | 1.8 | 12.2 | 26 (96%) | 24 (69%) |
SMG right | 0.87 | 0.72 | 0.92 | 1.2 | 0.9 | 2.5 | 3.1 | 1.9 | 10.1 | 27 (100%) | 24 (69%) |
Supragl. larynx | 0.65 | 0.11 | 0.86 | 3.5 | 1.0 | 13.3 | 9.6 | 3.0 | 28.7 | 11 (41%) | 9 (26%) |
Delineation agreement analysis
Results
Survey
DSC, MSD, HD95 and volumes
Brainstem
Organ at risk | International consensus guidelines [18] | Errors | Consequences of errors |
---|---|---|---|
Brainstem | Cranial: bottom section of the lateral ventricles Caudal: tip of the dens of C2 | Cranial: start when the brainstem becomes visible (all RO) Caudal: different interpretation of “tip” so a few slices difference | No impact on relevant dose parameter for precise NTCP (Dmax), depending on tumour location. But can effect estimated dose to spinal cord which has a more strict dose constraint |
Cochlea | CT scan in bone setting, cochlea in temporal bone | Incorrect location (2 RO) Entire petrous part of the temporal bone delineated (3 RO) | Effect on dose when wrong location is delineated Difference in volume can have an impact on Dmean and Dmax depending on tumour location |
Glottic area | Cranial: cranial tip of arytenoids Caudal: caudal edge of thyroid cartilage Posterior: cricoid, anterior border of arytenoids Enclosed by the thyroid cartilage | Entire larynx delineated, starting caudal of the hyoid and including the thyroid cartilage and arytenoids (2 RO) Included caudal part of supraglottic larynx (2 RO) Included arytenoids (2 RO) | Impact on relevant dose parameter for precise NTCP (Dmean) |
Mandible | CT scan in bone setting Excluding teeth, including mandibular condyles and coronoid process | Teeth included (not systematically, but some RO in some cases) Mandibular condyles and coronoid process not included (1 RO systematically) | No impact on relevant dose parameter for precise NTCP (Dmax), depending on tumour location |
Oral cavity | Cranial: Hard palate mucosa and mucosal reflections near the maxilla Caudal: base of tongue mucosa and hyoid posteriorly and the mylohyoid and anterior belly of the digastric muscle anteriorly Anterior and lateral: inner side of the mandible and maxilla Posterior: soft palate, uvula and base of tongue | Included teeth (two RO) Included the buccal mucosa (1 RO) Excluded posterior part of oral cavity (1 RO) Excluded base of tongue (1 RO) | Impact on relevant dose parameter for precise NTCP (Dmean) |
Parotid gland | Cranial: external auditory canal, mastoid process Caudal: posterior part submandibular space Anterior: Masseter muscle, posterior border mandibular bone, pterygoid muscle (med. and lat.) Posterior: sternocleidomastoid muscle, lateral side posterior belly digastric muscle Lateral: platysma and subcutaneous fat Medial: Posterior belly of the digastric muscle, styloid process, para-pharyngeal space | Cranial and caudal borders varied up to a few slices between RO Anterior: sometimes inclusion of the masseter and pterygoid muscles Medial: digastric muscle sometimes included | Impact on relevant dose parameter for precise NTCP (Dmean) |
PCM inferior [21] | Caudal: lower edge of arytenoids Cranial: first slice caudal to the hyoid bone | Caudal: several slices difference between RO | Impact on relevant dose parameter for precise NTCP (Dmean) |
PCM middle [21] | Cranial: cranial border of C3 Caudal: caudal border of hyoid bone | Cranial: cranial border stopped at caudal border of C3 (3 RO). Only 2 RO delineated cranially enough | Impact on relevant dose parameter for precise NTCP (Dmean) |
PCM superior [21] | Cranial: tips of the pterygoid plates (hamulus) Caudal: caudal border of C2 | Cranial: 1 RO delineated the superior muscle up to the base of skull | Impact on relevant dose parameter for precise NTCP (Dmean) |
Spinal cord | Spinal cord, not canal Cranial: tip of dens of C2 Caudal: At least cranial edge of T3, lower for more caudal tumours | Spinal canal delineated (2 RO) Cranial: some difference depending on what was interpreted as “tip” of dens of C2 Caudal: not caudal enough, stopped several slices too high (3 RO, each in one patient) | No impact on relevant dose parameter for precise NTCP (Dmax), depending on tumour location. But can effect estimated dose to brainstem which has a less strict dose constraint |
Submandibular gland | Cranial: medial pterygoid muscle and mylohyoid muscle Caudal: fatty tissue Anterior: lateral surface mylohyoid muscle and hyoglossus muscle Posterior: para-pharyngeal space, sternocleidomastoid muscle Lateral: medial surface medial pterygoid muscle, mandible, platysma Medial: lateral surface mylohyoid muscle, hyoglossus muscle, superior and middle PCM, anterior belly digastric muscle | Cranial: some variation in cranial border between RO | Impact on relevant dose parameter for precise NTCP (Dmean) |
Supraglottic larynx | Cranial: tip of epiglottis Caudal: cranial edge of arytenoids Posterior: inferior PCM, pharyngeal lumen Confined by the thyroid cartilage and hyoid bone, exclude pharyngeal lumen | Cranial: entire pharyngeal lumen delineated at the tip of the epiglottis (1 RO) Caudal: delineation 2–3 cm more caudal than guidelines (2 RO) | Impact on relevant dose parameter for precise NTCP (Dmean) |